An observational study in Congenital Melanocytar Nevi in the Lower Limb, sponsored by University Hospital, Montpellier. Completed at 1 site in France. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2020-06-05.
Sponsored by University Hospital, Montpellier · Observational
Depending on its dimensions, it is difficult to predict if a congenital nevi of the lower limb can be surgically removed by a unique simple procedure or by a complex procedure (expander, skin graft etc..), with a good result.
This study retrospectively reviewed the practice of our team of surgeons depending on the size of the naevus to reveal a dimension threshold that can be used in the future to help to choose between a simple or a complex procedure.
Retrospective study using medical file data only. No intervention nor phone call etc.. to the patients or their parents.
47 studies on the registry are indexed under Nevus; 9 are open to participants now.
This study's enrollment of 176 is above the median of 145 across 28 observational studies indexed under Nevus.
Browse Nevus studies →University Hospital, Montpellier is the lead sponsor of 1,261 studies on the registry; 224 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Children that had congenital nevi surgery removal, in the lower limb.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria:
Nevi Estimated Size
Nevi Estimated Size (centimeters)
Time frame: within three weeks after surgery
post-operative complications depending on the initial size of the naevus
post-operative complications depending on the initial size of the naevus : percentage of complication rate
Time frame: assessed within 6 months after surgery
Plan to share: Undecided — NC
No publications or documents are linked to this record.
This study is completed, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Montpellier →